Table 1.
Clinical and CMR characteristics of healthy volunteers
| Healthy volunteers, n = 20 | ||
|---|---|---|
| Clinical characteristics | ||
| Age (years) | 58.9 ± 11.2 | |
| Gender, n (female/male) | 6/14 | |
| BMI (kg/m2) | 23.6 ± 2.6 | |
| hsTnT (pg/l) | 5.8 (3–10), n = 6 | |
| NT-proBNP (µg/ml) | 87.8 (20–179), n = 6 | |
| GFR (ml/min/1.73 m2 [CKD-EPI]) | 89.0 ± 11.4 | |
| Creatinine (µmol/l) | 86.0 ± 11.8 | |
| Hypertension, n | 0 | n = 17 |
| Diabetes mellitus, n | 0 | |
| Hyperlipidaemia, n | 0 | |
| Smoking history, n | 0 | |
| Familiy history of CVD | 0 | |
| CMR characteristics | ||
| LVEDV (ml/m2) | 84.5 ± 13.0 | |
| LVESV (ml/m2) | 32.6 ± 6.1 | |
| LVEF (%) | 61.5 ± 3.3 | |
| LV mass (g/m2) | 48.6 ± 8.2 | |
| Septal thickness (mm) | 9.2 ± 1.9 | |
| Presence of LGE/total, n | 0/20 | |
| Native T1 value at 1.5T (ms) | 995.6 ± 20.2 | n = 10 |
| Native T1 value at 3T (ms) | 1241.1 ± 22.7 | n = 10 |
Values are expressed as mean ± SD. Number of patients are presented where it differed from the patient group
BMI body mass index, hsTnT high-sensitivity Troponin T, NT-proBPN N-terminal pro b-type natriuretic peptide, GFR glomerular filtration rate, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LV left ventricular, LGE late gadolinium enchancement